Harilal Patel

Outcomes of Desidustat Treatment in People with Anemia and Chronic Kidney Disease: A Phase 2 Study

Kevinkumar Kansagra, Jatin Patel, Shuchi Joshi et al. · American Journal of Nephrology · 2019 · 64 citations

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Oral NLRP3 Inflammasome Inhibitor ZYIL1: First‐in‐Human Phase 1 Studies (Single Ascending Dose and Multiple Ascending Dose)

Kevinkumar Kansagra, Taufik Momin, Hardik B. Patel et al. · Clinical Pharmacology in Drug Development · 2022 · 62 citations · Full text

Pharmacokinetics, Safety, and Tolerability of Saroglitazar (ZYH1), a Predominantly PPARα Agonist with Moderate PPARγ Agonist Activity in Healthy Human Subjects

Rajendrakumar H. Jani, Kevinkumar Kansagra, Mukul R. Jain et al. · Clinical Drug Investigation · 2013 · 58 citations · Full text

Synthesis and structure–activity relationship of potent, selective and orally active anthranilamide-based factor Xa inhibitors: Application of weakly basic sulfoximine group as novel S4 binding element

Vrajesh B. Pandya, Mukul R. Jain, Ganes Chakrabarti et al. · European Journal of Medicinal Chemistry · 2012 · 41 citations · Full text

Structure–activity Relationship, Medicinal Chemistry, Biochemistry +10

Phase I Clinical Study of ZYAN1, A Novel Prolyl-Hydroxylase (PHD) Inhibitor to Evaluate the Safety, Tolerability, and Pharmacokinetics Following Oral Administration in Healthy Volunteers

Kevinkumar Kansagra, Rajendrakumar H. Jani, Nuggehally R. Srinivas et al. · Clinical Pharmacokinetics · 2017 · 38 citations · Full text